Generic-Drug Co. Says To Think Again About 'Double Patenting'
An Indian generic-drug maker wants the whole Federal Circuit to take a closer look at the issue of "double patenting," telling it that a recent panel ruling mistakenly breathed new life...To view the full article, register now.
Already a subscriber? Click here to view full article